Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Jinxin Reproductive Medicine (01951.HK) by 7.45 million shares on November 3, 2025, marking a decrease of 0.52% [1][2] - Over the past five trading days, there have been four days of net reductions in holdings, totaling 8.89 million shares [1][2] - In the last 20 trading days, there were 11 days of net increases in holdings, amounting to a total of 15.63 million shares [1][2] Group 2 - As of now, southbound funds hold 1.436 billion shares of Jinxin Reproductive Medicine, which represents 52.07% of the company's total issued ordinary shares [1][2] - Jinxin Reproductive Medicine is an investment holding company primarily providing in vitro fertilization (IVF) services, along with various reproductive and medical services [2] - The company operates mainly in China and the United States, offering auxiliary reproductive services, management services, and sales of medical consumables and equipment [2]
锦欣生殖（01951.HK）：11月3日南向资金减持745.15万股